Academic · Private company
University of Washington
Track this companyFree. Adds University of Washington to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Adapting the "Do More, Feel Better" Intervention for Older People Living With HIVNA · NOT_YET_RECRUITING · started Nov 8, 2027ClinicalTrials.gov NCT07915934 · fetched Nov 12, 2026
- Polatuzumab Vedotin, Mosunetuzumab, and Acalabrutinib for the Treatment of Mantle Cell Lymphoma, PAcMan TrialPHASE2 · NOT_YET_RECRUITING · started Mar 1, 2027ClinicalTrials.gov NCT07910435 · fetched Nov 12, 2026
- A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell TransplantNA · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07616921 · fetched Nov 12, 2026
- VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body DementiaNA · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07637097 · fetched Nov 12, 2026
- Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA TrialPHASE2 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07332351 · fetched Nov 12, 2026
- Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic CancerPHASE1 · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07645651 · fetched Nov 12, 2026
- Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO TrialPHASE2 · RECRUITING · started Nov 15, 2026ClinicalTrials.gov NCT07698535 · fetched Nov 12, 2026
- E-Socket, Diagnostic MonitoringNA · RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT06432335 · fetched Nov 12, 2026
- Prosthetic Socket Fit Testing SystemNA · RECRUITING · started Oct 12, 2026ClinicalTrials.gov NCT07491614 · fetched Nov 12, 2026
- [18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed CholangiocarcinomaPHASE2 · RECRUITING · started Oct 8, 2026ClinicalTrials.gov NCT07673341 · fetched Nov 12, 2026
- IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of RecurrencePHASE2 · RECRUITING · started Sep 16, 2026ClinicalTrials.gov NCT07495124 · fetched Nov 12, 2026
- Dry Weight Reduction Intervention Via Extra UltrafiltrationNA · RECRUITING · started Sep 10, 2026ClinicalTrials.gov NCT07637110 · fetched Nov 12, 2026
- Finasteride and CutibacteriumPHASE4 · RECRUITING · started Aug 31, 2026ClinicalTrials.gov NCT07731802 · fetched Nov 12, 2026
- Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic MalignanciesPHASE2 · ACTIVE_NOT_RECRUITING · started May 19, 2026ClinicalTrials.gov NCT07336238 · fetched Nov 12, 2026
- Mobile App-Based Intervention to Improve Toothbrushing in Children and Teens With AutismNA · ENROLLING_BY_INVITATION · started May 7, 2026ClinicalTrials.gov NCT07446413 · fetched Nov 12, 2026
- Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin LymphomaPHASE2 · RECRUITING · started Dec 7, 2025ClinicalTrials.gov NCT07097363 · fetched Nov 12, 2026
- A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast CancerPHASE2 · RECRUITING · started Nov 17, 2025ClinicalTrials.gov NCT07112053 · fetched Nov 12, 2026
- Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2RECRUITING · started Nov 3, 2025ClinicalTrials.gov NCT07225127 · fetched Nov 12, 2026
- Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES StudyRECRUITING · started Jan 2, 2024ClinicalTrials.gov NCT06295965 · fetched Nov 12, 2026
- Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell LymphomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 26, 2023ClinicalTrials.gov NCT05455697 · fetched Nov 12, 2026
- Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After StrokeNA · RECRUITING · started Oct 1, 2022ClinicalTrials.gov NCT05591196 · fetched Nov 12, 2026
- Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid NeoplasmsPHASE1_PHASE2 · RECRUITING · started Feb 4, 2022ClinicalTrials.gov NCT04797767 · fetched Nov 12, 2026
- Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate CancerRECRUITING · started Apr 16, 2021ClinicalTrials.gov NCT04489719 · fetched Nov 12, 2026
- Investigating Auto Adjusting Dynamic AFONA · RECRUITING · started Nov 30, 2020ClinicalTrials.gov NCT04623853 · fetched Nov 12, 2026
- Non-contrast DWI for Supplemental ScreeningACTIVE_NOT_RECRUITING · started Jul 16, 2018ClinicalTrials.gov NCT03607552 · fetched Nov 12, 2026